Free Trial

Rhythm Pharmaceuticals (RYTM) Insider Trading & Ownership

Rhythm Pharmaceuticals logo
$58.50 -0.86 (-1.45%)
(As of 09:15 AM ET)

Rhythm Pharmaceuticals (NASDAQ:RYTM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
5.60%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$20.50 M
Get RYTM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Rhythm Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RYTM Insider Buying and Selling by Quarter

Rhythm Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/11/2024Jennifer Kayden LeeEVPSell66,861$66.33$4,434,890.13  
11/11/2024Joseph ShulmaninsiderSell13,281$66.44$882,389.64  
11/7/2024Pamela J CramerInsiderSell4,688$65.00$304,720.00  
9/17/2024Jennifer L GoodDirectorSell31,751$52.40$1,663,752.40  
9/10/2024Lynn A TetraultDirectorSell17,501$49.65$868,924.65  
9/9/2024Pamela J CramerInsiderSell4,099$50.03$205,072.97  
8/26/2024Lynn A TetraultDirectorSell4,300$50.01$215,043.00  
8/26/2024Pamela J CramerInsiderSell3,200$50.01$160,032.00  
8/9/2024Pamela J CramerInsiderSell49,006$45.15$2,212,620.90  
7/29/2024Pamela J CramerInsiderSell1,395$49.06$68,438.70  
7/16/2024Joseph ShulmanInsiderSell10,468$53.00$554,804.00  
7/12/2024Joseph ShulmanInsiderSell5,313$50.01$265,703.13  
5/9/2024Joseph ShulmanInsiderSell3,984$38.47$153,264.48  
4/2/2024Christopher Paul GermanCAOSell368$41.76$15,367.68  
3/21/2024Joseph ShulmanInsiderSell18,235$40.34$735,599.90  
3/19/2024David P MeekerCEOSell45,494$39.22$1,784,274.68  
3/19/2024Hunter C SmithCFOSell15,515$39.22$608,498.30  
3/19/2024Yann MazabraudEVPSell16,000$39.22$627,520.00  
2/14/2024Joseph ShulmanInsiderSell1,089$50.01$54,460.89  
2/12/2024Hunter C SmithCFOSell1,209$51.38$62,118.42  
2/12/2024Joseph ShulmanInsiderSell791$51.38$40,641.58  
2/12/2024Yann MazabraudEVPSell1,594$51.38$81,899.72  
2/9/2024Joseph ShulmanInsiderSell71,774$50.38$3,615,974.12  
12/27/2023Joseph ShulmanInsiderSell5,015$50.01$250,800.15  
12/5/2023Hunter C SmithCFOSell7,026$35.06$246,331.56  
11/24/2023Hunter C SmithCFOSell10,974$35.02$384,309.48  
(Data available from 1/1/2013 forward)

RYTM Insider Trading Activity - Frequently Asked Questions

The list of insiders at Rhythm Pharmaceuticals includes Christopher Paul German, David P Meeker, Hunter C Smith, Jennifer Chien, Jennifer Kayden Lee, Jennifer L Good, Joseph Shulman, Lynn A Tetrault, Pamela J Cramer, William T Roberts, and Yann Mazabraud. Learn more on insiders at RYTM.

5.60% of Rhythm Pharmaceuticals stock is owned by insiders. Learn more on RYTM's insider holdings.

The following insiders have sold RYTM shares in the last 24 months: Christopher Paul German ($15,367.68), David P Meeker ($1,784,274.68), Hunter C Smith ($1,358,789.18), Jennifer Chien ($50,033.17), Jennifer Kayden Lee ($5,088,901.25), Jennifer L Good ($1,663,752.40), Joseph Shulman ($6,568,523.87), Lynn A Tetrault ($1,083,967.65), Pamela J Cramer ($2,990,358.21), William T Roberts ($42,485.94), and Yann Mazabraud ($709,419.72).

Insiders have sold a total of 443,946 Rhythm Pharmaceuticals shares in the last 24 months for a total of $21,355,873.75 sold.

Rhythm Pharmaceuticals Key Executives



This page (NASDAQ:RYTM) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners